Heron Therapeutics, Inc. (LON: 0J4V)
London
· Delayed Price · Currency is GBP · Price in USD
1.692
+0.052 (3.15%)
Jan 23, 2025, 2:33 PM BST
Heron Therapeutics Employees
Heron Therapeutics had 126 employees as of December 30, 2023. The number of employees decreased by 77 or -37.93% compared to the previous year.
Employees
126
Change (1Y)
-77
Growth (1Y)
-37.93%
Revenue / Employee
815.60K GBP
Profits / Employee
-165.60K GBP
Market Cap
201.29M
Employees Chart
Related Stocks
Company Name | Employees |
---|---|
AstraZeneca | 89,900 |
GSK plc | 70,212 |
Haleon | 25,408 |
Smith & Nephew | 18,452 |
ConvaTec Group | 10,136 |
Hikma Pharmaceuticals | 9,100 |
HUTCHMED (China) | 1,988 |
Oxford Nanopore Technologies | 1,238 |
Heron Therapeutics News
- 4 weeks ago - Heron Therapeutics Announces Corporate Headquarters Relocation to Cary, North Carolina - PRNewsWire
- 7 weeks ago - Relief For Heron Therapeutics After The Court Win On Cinvanti - Seeking Alpha
- 7 weeks ago - U.S. District Court Upholds Validity of CINVANTI® Patents - PRNewsWire
- 2 months ago - Heron Therapeutics, Inc. (HRTX) Q3 2024 Earnings Call Transcript - Seeking Alpha
- 2 months ago - Heron Therapeutics Announces Third Quarter 2024 Financial Results and Narrows Financial Guidance - PRNewsWire
- 2 months ago - Heron Therapeutics Announces Appointment of Michael Kaseta to Board of Directors - PRNewsWire
- 3 months ago - Heron Therapeutics to Report Third Quarter 2024 Financial Results On Tuesday, November 12, 2024 - PRNewsWire
- 3 months ago - Heron Therapeutics Reaffirms Availability and Ample Supply of CINVANTI®, SUSTOL®, and APONVIE® as Alternatives During the Potential Shortage of Intravenous Fluids - PRNewsWire